Company Filing History:
2 out of 3 
1 out of 3,540 
Years Active: 2002-2012
Title: **Innovator Spotlight: Jay Chung**
Introduction
Jay Chung, an accomplished inventor based in Bethesda, MD, has made significant contributions to the field of medicine with his innovative research and patent filings. With a total of three patents to his name, he has focused primarily on the treatment of inflammation, showcasing his dedication to advancing therapeutic methods.
Latest Patents
Jay Chung's latest patents reflect his commitment to addressing inflammation-related health issues. His first patent, titled "Treatment of Inflammation Using BST2 Inhibitor," discloses a method that prevents immune cells from binding to other cells. By utilizing a composition comprising a BST2 antagonist, this invention aims to inhibit detrimental immune responses. Similarly, another patent, "Effect of BST2 on Inflammation," presents a comparable methodology emphasizing the importance of preventing immune cell binding through a composition containing a BST antagonist.
Career Highlights
Throughout his career, Jay Chung has collaborated with notable organizations, including Isu Abxis Co., Ltd. and The United States of America as represented by the Department of Health and Human Services. His work in these institutions has allowed him to take part in groundbreaking research and development efforts, further solidifying his reputation in the field.
Collaborations
During his innovative journey, Jay Chung has worked alongside talented colleagues, including Myung Kim and June-Young Park. Their collaborative efforts have contributed to developing novel approaches to tackle inflammation, enhancing the potential for impactful medical solutions.
Conclusion
In conclusion, Jay Chung stands out as a prominent figure in the world of medical inventions. His dedication to research and innovation, evidenced by his patents and collaborations, highlights his significant role in advancing treatments for inflammation. As the field of medicine continues to evolve, inventors like Jay Chung will remain at the forefront, driving meaningful change for patients and healthcare professionals alike.